PTC Therapeutics Inc logo

PTC Therapeutics Inc

€ 51.00 (+2.41%) Aug 15
P/E:
At Loss
P/B:
0
Market Cap:
€ 3.69B ($ 3.75B)
Enterprise V:
€ 3.78B ($ 3.85B)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap €:
3.69B
Market Cap $:
3.75B
PE Ratio:
At Loss
Avg Vol (2-Month):
-
Enterprise Value €:
3.78B
Enterprise Value $:
3.85B
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

PTC Therapeutics Inc
NAICS : 325412 SIC : 2834
100 Corporate Court, South Plainfield, NJ, USA, 07080
Description
PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
Name Current Vs Industry Vs History
Cash-To-Debt 0.84
Equity-to-Asset -0.1
Debt-to-Equity -3.29
Debt-to-EBITDA -1.66
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.1
Distress
Grey
Safe
Beneish M-Score -2.51
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 65.21
9-Day RSI 68.28
14-Day RSI 69.59
6-1 Month Momentum % 18.89
12-1 Month Momentum % 27.38

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.22
Quick Ratio 1.2
Cash Ratio 0.89
Days Inventory 160.16
Days Sales Outstanding 66.49
Days Payable 218.26

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.9

Financials (Next Earnings Date:2022-10-28 Est.)

FRA:BH3's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 555.798
EPS (TTM) (€) -7.035
Beta 0.39
Volatility % 48.5
14-Day RSI 69.59
14-Day ATR (€) 1.287384
20-Day SMA (€) 45.875
12-1 Month Momentum % 27.38
52-Week Range (€) 24.2 - 52.5
Shares Outstanding (Mil) 71.54

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PTC Therapeutics Inc Filings

Document Form Filing Date
No Filing Data